WuXi AppTec (OTCMKTS:WUXIF) Stock Price Up 5.4% – Still a Buy?

WuXi AppTec Co., Ltd. (OTCMKTS:WUXIF) shares were up 5.4% during trading on Monday. The company traded as high as $25.8450 and last traded at $25.8450. Approximately 436 shares were traded during trading, a decline of 81% from the average session volume of 2,287 shares. The stock had previously closed at $24.5250.

Recent WuXi AppTec Headlines

These are some of the WUXIF headlines that stood out recently:

• Positive Sentiment: The Pentagon’s removal of WuXi AppTec from the list followed a court win, easing the immediate risk associated with the designation. Reports said the company’s shares rose after the reversal. After court win, WuXi AppTec scores removal from US list of Chinese military companies
• Neutral Sentiment: The removal is a positive, specific change to the Pentagon designation, but does not by itself eliminate other potential U.S.-China policy or regulatory risks for the company. WuXi AppTec Removed From Pentagon’s Chinese Military Firms List

WuXi AppTec Stock Performance

The business has a 50-day moving average of $25.81 and a 200 day moving average of $19.51.

WuXi AppTec Company Profile

WuXi AppTec is a global pharmaceutical and healthcare services company that provides research, development and manufacturing support to pharmaceutical, biotechnology and medical device companies. Its open-access platform is designed to help customers advance products from early discovery through clinical development and commercial production. The company’s services include drug discovery, preclinical research, clinical research support, laboratory testing, contract development and manufacturing, and medical device testing.